Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China
· Delayed Price · Currency is CNY 9.17
-0.03 (-0.33%)
Jun 6, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Pharmaceutical Distribution | 3.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Distribution Growth | -4.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Infective Drugs | 1.73B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Infective Drugs Growth | -21.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Drugs | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Drugs Growth | -21.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-tumor Drugs | 851.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-tumor Drugs Growth | -12.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antiparasitic and Veterinary Drugs | 830.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antiparasitic and Veterinary Drugs Growth | -9.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Import of Finished Drugs and Promotion of Imported Preparations | 641.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Import of Finished Drugs and Promotion of Imported Preparations Growth | -30.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Drugs | 572.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Drugs Growth | 2.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endocrine Drugs | 343.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endocrine Drugs Growth | -1.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 215.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | -34.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 34.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -52.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 9.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -13.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign | 760.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign Growth | -4.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|